Company Filing History:
Years Active: 1997-1999
Title: The Innovative Contributions of Patricia A. Bacha
Introduction
Patricia A. Bacha is a notable inventor based in Hollis, NH (US), recognized for her significant contributions to the field of medical research. With a total of three patents to her name, she has made strides in developing innovative treatments for various health conditions.
Latest Patents
One of her latest patents focuses on epidermal growth factor receptor targeted molecules for the treatment of inflammatory arthritis. This invention features a method for treating patients suffering from this condition by administering a molecule that specifically binds to the epidermal growth factor receptor expressed on cells contributing to the patient's inflammatory arthritis. The molecule is designed to decrease the viability of these cells, offering a potential therapeutic approach. Another significant patent involves a mammalian model of a malignant disorder. This method outlines a process for producing a mouse with a systemic malignant disease that mimics a human IL-2 expressing T-cell malignancy. It includes administering a mixture of passaged cells comprising cancer-causing cells, which have been rendered cancer-causing through in vivo passage of tumor-inducing cells in athymic mice.
Career Highlights
Patricia A. Bacha is currently associated with Seragen, Inc., where she continues to advance her research and innovations. Her work has been instrumental in exploring new avenues for treatment and understanding complex diseases.
Collaborations
Patricia collaborates with Serene E. Forte, who is also a key figure in her research endeavors. Together, they contribute to the innovative landscape of medical science.
Conclusion
Patricia A. Bacha's work exemplifies the spirit of innovation in the medical field. Her patents reflect a commitment to improving patient outcomes through targeted therapies and advanced research methodologies.